H.J.Res. 54 · 110th Congress

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Stage
In committee
Sponsor
Anna Eshoo
Introduced
2007-09-27
Latest action
2007-11-08 · Referred to the Subcommittee on Health.

Subjects

Congress
Medicare
Health
Law
Cancer
Department of Health and Human Services
Government Operations and Politics
Social Welfare
Administrative procedure
Congressional veto
Blood